- Home
- TSVT vs PSF Comparison
TSVT vs PSF Comparison
Compare TSVT & PSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- PSF
- Stock Information
- Founded
- TSVT 2021
- PSF 2010
- Country
- TSVT United States
- PSF United States
- Employees
- TSVT N/A
- PSF N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- PSF Investment Managers
- Sector
- TSVT Health Care
- PSF Finance
- Exchange
- TSVT Nasdaq
- PSF Nasdaq
- Market Cap
- TSVT 253.9M
- PSF 256.1M
- IPO Year
- TSVT N/A
- PSF N/A
- Fundamental
- Price
- TSVT $5.01
- PSF $21.21
- Analyst Decision
- TSVT Buy
- PSF
- Analyst Count
- TSVT 6
- PSF 0
- Target Price
- TSVT $10.40
- PSF N/A
- AVG Volume (30 Days)
- TSVT 321.7K
- PSF 25.0K
- Earning Date
- TSVT 11-12-2024
- PSF 01-01-0001
- Dividend Yield
- TSVT N/A
- PSF 7.69%
- EPS Growth
- TSVT N/A
- PSF N/A
- EPS
- TSVT N/A
- PSF N/A
- Revenue
- TSVT $44,120,000.00
- PSF N/A
- Revenue This Year
- TSVT N/A
- PSF N/A
- Revenue Next Year
- TSVT $22.42
- PSF N/A
- P/E Ratio
- TSVT N/A
- PSF N/A
- Revenue Growth
- TSVT N/A
- PSF N/A
- 52 Week Low
- TSVT $1.54
- PSF $16.00
- 52 Week High
- TSVT $6.40
- PSF $20.19
- Technical
- Relative Strength Index (RSI)
- TSVT 57.72
- PSF 60.05
- Support Level
- TSVT $4.60
- PSF $21.11
- Resistance Level
- TSVT $4.90
- PSF $21.39
- Average True Range (ATR)
- TSVT 0.31
- PSF 0.16
- MACD
- TSVT 0.01
- PSF -0.05
- Stochastic Oscillator
- TSVT 98.16
- PSF 21.35
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About PSF Cohen & Steers Select Preferred and Income Fund Inc.
Cohen & Steers Select Preferred and Income Fund Inc is a diversified, closed-end investment company. The Fund's primary investment objective is high current income with capital appreciation as its secondary objective. The Fund invests at least of its Managed Assets in preferred and other income securities issued by U.S. and non-U.S. companies.